Evidence map›Paper›PMID 35434126›Full record

ArticleBioMed research international2022

Upregulation of Synuclein-

Jie Yang, Yangyang Pan, Lu Peng, Licui Zhang, Juan Zhao, Zhihong Zheng, Jun Zheng, Xiaoli Xu, Yan Zeng

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie Yang *Key Laboratory of Xinjiang Endemic and Ethnic Diseases, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Yangyang Pan *Key Laboratory of Xinjiang Endemic and Ethnic Diseases, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Lu PengDepartment of Stomatology, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Licui ZhangDepartment of Laboratory, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Juan ZhaoKey Laboratory of Xinjiang Endemic and Ethnic Diseases, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Zhihong ZhengKey Laboratory of Xinjiang Endemic and Ethnic Diseases, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Jun ZhengDepartment of Stomatology, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Xiaoli XuDepartment of Hematology, The First People's Hospital of Foshan, Foshan, Guangdong, China.ORCID https://orcid.org/0000-0002-0286-545X
Yan ZengKey Laboratory of Xinjiang Endemic and Ethnic Diseases, School of Medicine, Shihezi University, Shihezi, Xinjiang, China.ORCID https://orcid.org/0000-0002-9823-1266
Shihezi University · CNFirst People's Hospital of Foshan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synuclein-

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsBiomarkers, Tumorgamma-SynucleinHumansNeoplasm ProteinsPrognosisSnail Family Transcription FactorsSquamous Cell Carcinoma of Head and NeckUp-RegulationBiomarkers, Tumorgamma-SynucleinNeoplasm ProteinsSNAI1 protein, humanSnail Family Transcription FactorsSNCG protein, human

Identifiers

PMID35434126
PMCPMC9010211
OpenAlexW4226316288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.